Latest Breaking News On - Lucile dzen - Page 1 : vimarsana.com

Inventiva announces two scientific presentations at the EASL International Liver Congress™ 2024

The first abstract demonstrates that the improvements of MACK-3, a diagnostic test for metabolic dysfunction-associated steatohepatitis, parallel the histological response to lanifibranor therapy in.

United statesNew yorkMichaelp cooremanManalf abdelmalekLucile dzenLuisa vonghiaPierre broquaWilhelmusj kwantenJean louis junienMartine baudinGuillaume wettsteinSven francquePhilippe huot marchantShivani chotkoeAude lepreuxPascaline clerc

INVENTIVA: Inventiva announces two scientific presentations at the EASL International Liver Congress 2024

The first abstract demonstrates that the improvements of MACK-3, a diagnostic test for metabolic dysfunction-associated steatohepatitis, parallel the histological response to lanifibranor therapy in patients

New yorkUnited statesLuisa vonghiaManalf abdelmalekPierre broquaLucile dzenPhilippe huot marchantSven francqueJean louis junienMichaelp cooremanMartine baudinWilhelmusj kwantenPascaline clercShivani chotkoeAude lepreuxGuillaume wettstein

Inventiva announces a late breaker abstract and two additional abstracts on its lead compound, lanifibranor, at the AASLD The Liver Meeting® 2023

The phase II study led by Dr. Kenneth Cusi evaluating lanifibranor in patients with T2D and MASLD was selected as late breaker.Two additional scientific abstracts from the NATIVE Phase IIb clinical trial evaluating lanifibranor for the treatment of patients with NASH have been selected for presentation. The two abstracts show: the correlation between the increase of adiponectin under lanifibranor and the improvement of histological and serum markers of NASH severity both in terms of activity and

Israel generalUnited statesNew yorkMartine baudinLouis griffelJean louis junienRomina lomonacoSven francqueSrilaxmi kalavalapalliManalf abdelmalekPhilippe huot marchandEddison godinez leivaPierre broquaAude lepreuxLucile dzenMichaelp cooreman

Inventiva Announces A Late Breaker Abstract And Two Additional Abstracts On Its Lead Compound, Lanifibranor, At The AASLD The Liver Meeting® 2023

Inventiva Announces A Late Breaker Abstract And Two Additional Abstracts On Its Lead Compound, Lanifibranor, At The AASLD The Liver Meeting® 2023
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesIsrael generalNew yorkMichaelp cooremanPierre broquaSrilaxmi kalavalapalliMartine baudinPhilippe huot marchandAndrea ortiz rochaEddison godinez leivaLouis griffelManalf abdelmalekLucile dzenSven francqueRomina lomonacoPascaline clerc

INVENTIVA: Inventiva announces five scientific presentations at the EASL International Liver Congress 2023

Five poster presentations showing: the correlation between the improvement of hepatic steatosis and a robust increase in adiponectin levels, improvement in lipid profile and glycemic control in patients

New yorkUnited statesMecklenburg vorpommernMichaelp cooremanLindsey devisscherStephena harrisonSven francqueAnneleen heldensJean louis junienShivani chotkoeHans van vlierberghePhilippe huot marchantBenedicte descampsPierre broquaManalf abdelmalekPascaline clerc